Journal of Korean Biological Nursing Science

  • 제23권4호
  • /
  • Pages.318-329
  • /
  • 2021
  • /
  • 2383-6415(pISSN)
  • /
  • 2383-6423(eISSN)
한국기초간호학회 (Korean society of Biological Nursing Science)
권호 표지
DOI QR코드

DOI QR Code

중소병원 의료기관 종사자의 COVID-19 AstraZeneca (ChAdOx1) 백신 접종 영향요인과 접종 후 이상 반응 실태조사

Factors Influencing COVID-19 AstraZeneca (ChAdOx1) Vaccination and Side Effects among Health Care Workers in an Acute General Hospital

  • 투고 : 2021.10.08
  • 심사 : 2021.11.22
  • 발행 : 2021.11.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Purpose: This study was conducted to identify factors affecting COVID-19 vaccination and associated side effects among health care workers in a small and medium-sized hospital. Methods: In May 2021, 301 workers out of a total of 670 working in a small and medium-sized hospital in Gyeonggi-do, were surveyed. The small and medium-sized hospital treats patients with COVID-19. Health care workers across different medical institutions responded with self-reported internet questionnaires. Factors influencing COVID-19 vaccination were analyzed via logistic regression. Results: Out of 301 subjects, 89.0% showed an intention to inoculate, and 85.7% were vaccinated against COVID-19. The most frequent reason for vaccination was responsibility as a medical worker. The fear of adverse reactions was the most frequent reason for non-vaccination. Adverse reactions after inoculation occurred in 70.9% of cases, and 30.6% were referred for treatment of adverse reactions. The factors ultimately influencing COVID-19 vaccination were vaccination intention, previous side effects from other vaccinations, occupation, and age. Conclusion: In order to improve the effectiveness of COVID-19 vaccination, a systematic approach is required to determine the risk factors associated with the young age of the administrative staff/personnel, subjects with a history of side effects associated with other vaccines, and health care workers who do not intend to be vaccinated. It is important to develop strategies to improve immunization. In addition, accurate and essential information regarding the side effects of vaccination is needed, along with appropriate education and publicity.

키워드

참고문헌

  1. Karlsson LC, Soveri A, Lewandowsky S, Karlsson L, Karlsson H, Nolvi S, et al. Fearing the disease or the vaccine: the case of COVID-19. Personality and Individual Differences 2021;172;110590. https://doi.org/10.1016/j.paid.2020.110590
  2. Brundage JF, Shanks DG. Deaths from bacterial pneumonia during 1918-19 influenza pandemic. Emerging Infectious Diseases 2008;14(8):1193-1199. https://doi.org/10.3201/eid1408.071313
  3. World Health Organization. WHO Coronavirus disease (COVID-19) dashboard [Internet] Geneva: World Health Organization; 2021 [citied 2021 March 23].Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019
  4. Gi MR, Kim DJ, Kim MN, Kim BS, Kim WY, Kim JO. et al. Vaccine effectiveness of Influenza A (H1N1). Academic research service project final result report. Osong: Korea Disease Control and Prevention Agency; 2010 Nov, Report No.: 2009-E00708-00.
  5. Chambers C. Using observational epidemiology to evaluate COVID-19 vaccines: integrating traditional methods with new data sources and tools. Canadian Journal of Public Health 2021;112:867-871, https://doi.org/10.17269/S41997-021-00554-Z
  6. Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Parvinder K, et al. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 NCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. The Lancet 2021;397(10277):881-891. https://doi.org/10.1016/S0140-6736(21)00432-3
  7. Korea Disease Control and Prevention Agency. COVID-19 infection [Internet] Osong: Korea Disease Control and Prevention Agency; 2021 [citied 2021 February 26]. Available from: http://www.kdca.go.kr/board/board.es
  8. Government of the United Kingdom. Decision summary of product characteristics for vaxzevria [Internet]. London: Government of the United Kingdom; 2021 [citied 2021 March 29].Available from: https://www.gov.uk/government/ publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/information-for-healthcare-professionals-on-covid-19-vaccine-astrazeneca
  9. Kim SH, Wi YM, Yun SY, Ryu JS, Shin JM, Lee EH, et al. Adverse events in healthcare workers after the first dose of ChAdOx1 NCoV-19 or BNT162b2 MRNA COVID-19 vaccination: a single center experience. Journal of Korean Medical Science. 2021;36(4):1-8. https://doi.org/110.3346/JKMS.2021.36.E107
  10. Bae SM, Lee YW, Lim SY, Lee JH, Lim JS, Lee SJ, et al. Adverse reactions following the first dose of ChAdOx1 NCoV-19 vaccine and BNT162b2 vaccine for healthcare workers in South Korea. Journal of Korean Medical Science 2021; 36(17):e115. https://doi.org/10.3346/jkms.2021.36.e115
  11. Korean Society of Infectious Diseases. Adult immunization guidelines FAQ [Internet]. Seoul: Korean Society of Infectious Diseases; 2019 [citied 2021 March 23]. Available from: http://www.ksid.or.kr/file/qna.pdf
  12. Sarkanen T, Alakuijala A, Julkunen I, Partinen M. Narcolepsy associated with pandemrix vaccine. Current Neurology and Neuroscience Reports 2018;18(7):1-10. https://doi.org/10.1007/S11910-018-0851-5
  13. Dube E, MacDonald NE. Vaccine hesitancy: an over view. Human vaccines & immunotherapeutics 9.8 Oxford, Oxford University Press. 2018;1763-1773 https://doi.org/10.1093/ACREFORE/9780190632366.013.63
  14. Ledda C, Costantino C, Cuccia M, Maltezou HC, Rapisarda V. Attitudes of healthcare personnel towards vaccinations before and during the COVID-19 pandemic. International Journal of Environmental Research and Public Health 2021;18(5):2703. https://doi.org/10.3390/IJERPH18052703
  15. Szmyd B, Karuga FF, Bartoszek A, StanieckaK, Siwecka N, Bartoszek A, et al. Attitude and behaviors towards SARS-CoV-2 vaccination among healthcare workers: a cross-sectional study from Poland. Vaccines 2021;9(3):218. https://doi.org/10.3390/VACCINES9030218
  16. Dzieciolowska S, Hamel D, Gadio S, Dionne M, Gagnon D, Robitaille L, et al. Covid-19 vaccine acceptance, hesitancy, and refusal among Canadian healthcare workers: a multicenter survey. American Journal of Infection Control. 2021;36(5):309-384. https://doi.org/10.1016/J.AJIC.2021.04.079
  17. Gadoth A, Halbrook M, Martin-Blais R, Gray A, Tobin NH, Ferbas KG, et al. COVID-19 vaccine acceptance among health care workers in Los Angeles. Annals of Internal Medicine. 2021;174(6):882-885. https://doi.org/10.7326/m20-7580
  18. Central Disaster Management Headquarters, Central Disease Control Headquarters. Disease-19, Republic of Korea [Internet]. Sejong: Ministry of Health and Welfare; 2021 [citied 2021 March 2]. Available from: http://ncov.mohw.go.kr/en/
  19. Kwok KO, Li KK, Wei WI, Tang A, Wong SYS, Lee SS. Influenza vaccine uptake, COVID-19 vaccination intention and vaccine hesitancy among nurses: a survey international Journal of Nursing Studies. 2021;114:103854 https://doi.org/10.1016/j.ijnurstu.2020.103854
  20. Korea Disease Control and Prevention Agency. Guidelines for adverse reactions after vaccination against COVID-19 [Internet]. Osong: Korea Disease Control and Prevention Agency; 2021[citied 2021 July 17]. Available from: https://ncv.kdca.go.kr/board.es?mid=a12101000000&bid=0031#content
  21. Ramasamy MN, Minassian AM, Ewer KJ, Flaxman AL, Folegatti PM, Owens DR, et al. Safety and immunogenicity of ChAdOx1 NCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a singleblind, randomised, controlled, phase 2/3 trial. The Lancet. 2020;396(20267):1979-1993. https://doi.org/10.1016/S0140-6736(20)32466-1
  22. Detoc M, Bruel S, Frappe P, Tardy B, Botelho-Nevers E, Gagneux-Brunona A. intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic. Vaccine. 2020;38(45):7002-7006.https://doi.org/10.1016/j.vaccine.2020.09.041
  23. Dror AA, Eisenbach N, Taiber S. Morozov NG, Mizrachi M, Zigron A, et al. Vaccine hesitancy: the next challenge in the fight against COVID-19. European Journal of Epidemiology. 2020;35:8:775-779. https://doi.org/10.1007/s10654-020-00671-y
  24. Amandine GB, Detoc M, Bruel S, Tardy B, Rozaire O, Frappe P, et al. Intention to get vaccinations against COVID-19 in French healthcare workers during the first pandemic wave: a cross-sectional survey. Journal of Hospital Infection. 2021;108:168-173. https://doi.org/10.1016/j.jhin.2020.11.020
  25. Gerussi V, Peghin M, Palese A, Bressan V, Visintini E, Bontempo G, et al. Vaccine hesitancy among Italian patients recovered from COVID-19 infection towards influenza and Sars-Cov-2 vaccination. Vaccines. 2021;9(2):172. https://doi.org/10.3390/vaccines9020172
  26. Thaker J. The persistence of vaccine hesitancy: COVID-19 vaccination intention in New Zealand. Journal of Health Communication 2021;26(2):104-111. https://doi.org/10.1080/10810730.2021.1899346
  27. Ruiz JB, Bell RA. Predictors of intention to vaccinate against COVID-19: results of a nationwide survey. Vaccine. 2021;39(7):1080-1086. https://doi.org/10.1016/j.vaccine.2021.01.010
  28. Albitar O, Ballouze R, Jer PO, Ooi JP, Sheikh Ghadzi SM. Risk factors for mortality among COVID-19 patients. Diabetes Research and Clinical Practice. 2020;166:108293.https://doi.org/10.1016/j.diabres.2020.108293
  29. Amyn AM, SarahAnn MM, Jad E, Saad BO. Determinants of COVID-19 vaccine acceptance in the US. Clinical Medicine 2020;26:100495. https://doi.org/10.1016/J.ECLINM.2020.100495
  30. Qattan A, Alshareef N, Alsharqi O, Rahahleh NA, Chirwa GC, Al-Hanawi MK. Acceptability of a COVID-19 vaccine among healthcare workers in the Kingdom of Saudi Arabia. Frontiers in Medicine 2021;8:644300. https://doi.org/10.3389/FMED.2021.644300
  31. Wilson R, Zaytseva A, Bocquier A, Nokri A, Fressard L, Chamboredon P, et al. Vaccine hesitancy and self-vaccination behaviors among nurses in Southeastern France. Vaccine. 2020;38(5):1144-1151. https://doi.org/10.1016/j.vaccine.2019.11.018
  32. Schmid P, Rauber D, Betsch C, Lidolt G, Denker ML. Barriers of influenza vaccination intention and behavior-a systematic review of influenza vaccine hesitancy, 2005-2016. PLoS one. 2017;12(1):e0170550. https://doi.org/10.1371/JOURNAL.PONE.0170550
  33. Kuter BJ, Browne S, Momplaisir FM, Feemster KA, Shen AK, Green-McKenzie J, et al. Perspectives on the receipt of a COVID-19 vaccine: a survey of employees in two large hospitals in Philadelphia. Vaccine. 2021;39(12):1693-1700. https://doi.org/10.1016/j.vaccine.2021.02.029
  34. Caserotti M, Girardi P, Rubaltelli E, Tasso A, Lotto L, Gavaruzzi T. Associations of COVID-19 risk perception with vaccine hesitancy over time for Italian residents. Social Science & Medicine. 2021;272:113688. https://doi.org/10.1016/j.socscimed.2021.113688
  35. Jana S, Telisa S, Kathryn BA, Samantha H, Stephen JT, Daniel AS, et al Assessment of US healthcare personnel attitudes towards coronavirus disease 2019 (COVID-19) vaccination in a arge university healthcare system. Clinical Infectious Diseases. 2021;17(6):1612-1621. https://doi.org/10.1093/CID/CIAB054
  36. Sherman SM, Smith LE, Sim J, Amlotc R, Cutts M, Dasch H, et al. COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey. Human vaccines & Immunotherapeutics 2020;17(6):1612-1621. https://doi.org/10.1080/21645515.2020.1846397